Cited by 45Advanced Glycation End Products researchNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Role of RAGE in the Pathogenesis of Neurological Disorders

Open access
Juranek, Judyta, Mukherjee, Konark, Kordas, Bernard, Załęcki, Michał, Korytko, Agnieszka, Zglejc-Waszak, Kamila, Szuszkiewicz, Jarosław, Banach, Marta·2022·Neuroscience Bulletin

Abstract

This review reflects upon our own as well as other investigators' studies on the role of receptor for advanced glycation end-products (RAGE), bringing up the latest information on RAGE in physiology and pathology of the nervous system. Over the last ten years, major progress has been made in uncovering many of RAGE-ligand interactions and signaling pathways in nervous tissue; however, the translation of these discoveries into clinical practice has not come to fruition yet. This is likely, in part to be the result of our incomplete understanding of this crucial signaling pathway. Clinical trials examining the therapeutic efficacy of blocking RAGE-external ligand interactions by genetically engineered soluble RAGE or an endogenous RAGE antagonist, has not stood up to its promise; however, other trials with different blocking agents are being considered with hope for therapeutic success in diseases of the nervous system.

Integrity signals

Registry

Crossref · 10.1007/s12264-022-00878-x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RAGE belongs to the group of PRR receptors that can interact with DAMPs or PAMPs to induce an innate immune response.

    “RAGE belongs to the group of PRR receptors that can interact with DAMPs or PAMPs to induce an innate immune response.323”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [323]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Juranek, J., Mukherjee, K., Kordas, B., Załęcki, M., Korytko, A., Zglejc-Waszak, K., Szuszkiewicz, J., & Banach, M.
Affiliations
  • University of Warmia and Mazury in Olsztyn (PL)
  • Virginia Tech (US)
  • Jagiellonian University (PL)
Corresponding author
  • Juranek, Judyta
  • Banach, Marta
Venue
Neuroscience Bulletin
Published
2022-06-21
Volume
38
Issue
10
Pages
1248-1262
ISSN
  • 1995-8218 (ISSN-L)
  • 1673-7067
OpenAlex
W4283264051
Cited by
45
References
8
Citations by year
2026: 5 · 2025: 17 · 2024: 12 · 2023: 9 · 2022: 2
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • Neuroscience Bulletin (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
receptor for advanced glycation end products, RAGE, neurological disorders, signaling pathways, soluble RAGE, RAGE antagonists, neuroprotection, clinical trials
MeSH terms
Receptor for Advanced Glycation End Products, Humans, Ligands, Nervous System Diseases, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review